New Era In Drug Packaging: Redefining Safety, Sustainability
In an era that happens to be marked by quick advancements in biotechnology as well as pharmaceuticals, the evolution when it comes to drug...
Building A Long-Lasting Future For The Biopharma Sector
As part of the worldwide efforts to address climate change, the biopharma industry happens to be committed to decarbonizing its operations and, at the...
44% Predict Biotech Funding Recovery In 2024, Says Survey
The recent survey from GlobalData- The State of the Biopharmaceutical Industry 2024, went on to reveal that 44% of the healthcare industry professionals that...
Continuous Bioprocessing Impacts Modern Biopharma Production
The biopharmaceutical industry happens to be experiencing a massive shift toward continuous bioprocessing. Unlike traditional batch processing, which happens to be involving discrete stages...
Analytics & Mass Spec Enable Biotherapeutic Drug Development
In the modern era, biopharmaceutical discovery and development scientists happen to be achieving new levels when it comes to structural insight into therapeutic proteins....
Biopharma Commits Offering Equitable Access In Pandemics
The 77th World Health Assembly- WHA goes on to mark the deadline for the conclusion of a pandemic agreement as well as amended International...
The Clinical Trial Participation Added More Seamlessness
Verified Clinical Trials is all set to integrate its research participation verification tools with the clinical trial automation platform of ProofPilot in a new...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...